Currently viewing the category: "Novartis"

Newly approved hypertension treatment Valturna combines Diovan & Tekturna in a single pill

By · 13 Comments

A new blood-pressure treatment has come on the market that is of potential interest to hypertension patients whose blood pressure is not being adequately controlled with monotherapy.

Last month, the US Food and Drug Administration (FDA) approved Novartis’ Valturna (aliskiren and valsartan), which combines in a single [...]

Continue Reading →

Novartis patent bid rejected in India

By · 1 Comment

An Indian court has rejected Novartis’ challenge of a law that denies patent protection to drugs that are only minor improvements to earlier drugs. Novartis’ challenge came after the Indian government allowed drug companies to make generic versions of the cancer drug Gleevec.

This is great news for consumers — both because it enables [...]

Continue Reading →